Entremed (ENMD)

[tborges]

Why so quiet at Entremed???

Dr. Ren: “In terms of our outlook for 2013, we remain focused on building a leading oncology enterprise that integrates US and China strategies and resources for cost effective drug development. We intend to achieve the following objectives:

Continue the development of ENMD-2076, including initiating global clinical trials with sites in China under our U.S. FDA IND, and in parallel, pursuing local development in China under SFDA;
Pursue an additional clinical-stage drug candidate to add to our pipeline; Further develop our regulatory and clinical capability in China."

Only two trials are open and recruiting patients. The TNBC Phase 2 trial currently underway was originally scheduled to collect primary data by January 2014. However, this will depend upon successfully enrolling the target of 34 patients.

The recently started trial for soft tissue sarcoma is scheduled to be completed by April 2015... again dependent upon successful completion of enrollment of 25 patients.

It appears that the news most likely to surface in the short term will be administrative... i.e., progress with the China venture and the potential commencement of trials in China...